biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by jdstoxon Feb 04, 2018 12:42pm

166 Views

Post# 27499278

RE:RE:RE:Tailwinds removes BTI from model portfolio

Rollback, digitel?

We don't have that many shares outstanding.

We consistently show the ability to raise money.

Rolling back for the purpose of satisfying a US listing agreement doesn't change the market cap.

Making the business case is damaged with a rollback.

Would regulators allow it?

Would shareholders vote for it?

But tell us more, digtitel. The more we learn about how little you've learned, the better.

jdstox

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price